These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 28694498)

  • 1. Analysis of positive and negative allosteric modulation in metabotropic glutamate receptors 4 and 5 with a dual ligand.
    Dalton JAR; Pin JP; Giraldo J
    Sci Rep; 2017 Jul; 7(1):4944. PubMed ID: 28694498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational analysis and molecular modeling of the binding pocket of the metabotropic glutamate 5 receptor negative modulator 2-methyl-6-(phenylethynyl)-pyridine.
    Malherbe P; Kratochwil N; Zenner MT; Piussi J; Diener C; Kratzeisen C; Fischer C; Porter RH
    Mol Pharmacol; 2003 Oct; 64(4):823-32. PubMed ID: 14500738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shining Light on an mGlu5 Photoswitchable NAM: A Theoretical Perspective.
    Dalton JA; Lans I; Rovira X; Malhaire F; Gómez-Santacana X; Pittolo S; Gorostiza P; Llebaria A; Goudet C; Pin JP; Giraldo J
    Curr Neuropharmacol; 2016; 14(5):441-54. PubMed ID: 26391742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A close structural analog of 2-methyl-6-(phenylethynyl)-pyridine acts as a neutral allosteric site ligand on metabotropic glutamate receptor subtype 5 and blocks the effects of multiple allosteric modulators.
    Rodriguez AL; Nong Y; Sekaran NK; Alagille D; Tamagnan GD; Conn PJ
    Mol Pharmacol; 2005 Dec; 68(6):1793-802. PubMed ID: 16155210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allosteric Binding Site and Activation Mechanism of Class C G-Protein Coupled Receptors: Metabotropic Glutamate Receptor Family.
    Feng Z; Ma S; Hu G; Xie XQ
    AAPS J; 2015 May; 17(3):737-53. PubMed ID: 25762450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-{4-Chloro-2-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]phenyl}-2-hydroxybenzamide (CPPHA) acts through a novel site as a positive allosteric modulator of group 1 metabotropic glutamate receptors.
    Chen Y; Goudet C; Pin JP; Conn PJ
    Mol Pharmacol; 2008 Mar; 73(3):909-18. PubMed ID: 18056795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights into the interaction of negative allosteric modulators with the metabotropic glutamate receptor 5: discovery and computational modeling of a new series of ligands with nanomolar affinity.
    Anighoro A; Graziani D; Bettinelli I; Cilia A; De Toma C; Longhi M; Mangiarotti F; Menegon S; Pirona L; Poggesi E; Riva C; Rastelli G
    Bioorg Med Chem; 2015 Jul; 23(13):3040-58. PubMed ID: 26014480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preferential binding of allosteric modulators to active and inactive conformational states of metabotropic glutamate receptors.
    Yanamala N; Tirupula KC; Klein-Seetharaman J
    BMC Bioinformatics; 2008; 9 Suppl 1(Suppl 1):S16. PubMed ID: 18315847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allosteric modulation of metabotropic glutamate receptors by chloride ions.
    Tora AS; Rovira X; Dione I; Bertrand HO; Brabet I; De Koninck Y; Doyon N; Pin JP; Acher F; Goudet C
    FASEB J; 2015 Oct; 29(10):4174-88. PubMed ID: 26116702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overlapping binding sites drive allosteric agonism and positive cooperativity in type 4 metabotropic glutamate receptors.
    Rovira X; Malhaire F; Scholler P; Rodrigo J; Gonzalez-Bulnes P; Llebaria A; Pin JP; Giraldo J; Goudet C
    FASEB J; 2015 Jan; 29(1):116-30. PubMed ID: 25342125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heptahelical domain of metabotropic glutamate receptor 5 behaves like rhodopsin-like receptors.
    Goudet C; Gaven F; Kniazeff J; Vol C; Liu J; Cohen-Gonsaud M; Acher F; Prézeau L; Pin JP
    Proc Natl Acad Sci U S A; 2004 Jan; 101(1):378-83. PubMed ID: 14691258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the mGluR allosteric modulation in the NMDA-hypofunction model of schizophrenia.
    Doreulee N; Alania M; Mitaishvili E; Chikovani M; Chkhartishvili B
    Georgian Med News; 2009 Dec; (177):59-65. PubMed ID: 20090156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional modulation of G-protein coupled receptors during Parkinson disease-like neurodegeneration.
    Jenkins BG; Zhu A; Poutiainen P; Choi JK; Kil KE; Zhang Z; Kuruppu D; Aytan N; Dedeoglu A; Brownell AL
    Neuropharmacology; 2016 Sep; 108():462-73. PubMed ID: 26581500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subtype-selective mechanisms of negative allosteric modulators binding to group I metabotropic glutamate receptors.
    Fu TT; Tu G; Ping M; Zheng GX; Yang FY; Yang JY; Zhang Y; Yao XJ; Xue WW; Zhu F
    Acta Pharmacol Sin; 2021 Aug; 42(8):1354-1367. PubMed ID: 33122823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the active conformation of cyclohexane carboxylate positive allosteric modulators of the type 4 metabotropic glutamate receptor.
    Rovira X; Harrak Y; Trapero A; González-Bulnes P; Malhaire F; Pin JP; Goudet C; Giraldo J; Llebaria A
    ChemMedChem; 2014 Dec; 9(12):2685-98. PubMed ID: 25196639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetic and system bias as drivers of metabotropic glutamate receptor 5 allosteric modulator pharmacology.
    Sengmany K; Hellyer SD; Albold S; Wang T; Conn PJ; May LT; Christopoulos A; Leach K; Gregory KJ
    Neuropharmacology; 2019 May; 149():83-96. PubMed ID: 30763654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allosteric control of an asymmetric transduction in a G protein-coupled receptor heterodimer.
    Liu J; Zhang Z; Moreno-Delgado D; Dalton JA; Rovira X; Trapero A; Goudet C; Llebaria A; Giraldo J; Yuan Q; Rondard P; Huang S; Liu J; Pin JP
    Elife; 2017 Aug; 6():. PubMed ID: 28829739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and Antiparkinsonian Activity of VU0418506, a Selective Positive Allosteric Modulator of Metabotropic Glutamate Receptor 4 Homomers without Activity at mGlu2/4 Heteromers.
    Niswender CM; Jones CK; Lin X; Bubser M; Thompson Gray A; Blobaum AL; Engers DW; Rodriguez AL; Loch MT; Daniels JS; Lindsley CW; Hopkins CR; Javitch JA; Conn PJ
    ACS Chem Neurosci; 2016 Sep; 7(9):1201-11. PubMed ID: 27441572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The computational modeling of allosteric modulation of metabotropic glutamate receptors.
    Pérez-Benito L; Llinas Del Torrent C; Pardo L; Tresadern G
    Adv Pharmacol; 2020; 88():1-33. PubMed ID: 32416864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure of a class C GPCR metabotropic glutamate receptor 1 bound to an allosteric modulator.
    Wu H; Wang C; Gregory KJ; Han GW; Cho HP; Xia Y; Niswender CM; Katritch V; Meiler J; Cherezov V; Conn PJ; Stevens RC
    Science; 2014 Apr; 344(6179):58-64. PubMed ID: 24603153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.